New

Gastrointestinal Cancer Devices Market

2021

Gastrointestinal Cancer Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment Type (Surgery, Targeted Drugs Therapy, Chemo Therapy, Radiation Therapy); End User (Hospitals, Ambulatory Surgery Centers, Others); and Geography

| Report Code: TIPRE00018054 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Gastrointestinal Cancer Devices Market 2028 By Treatment Type, End User, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Gastrointestinal cancer is a type of malignant tumor which has negative impact on the digestive tract and gastrointestinal system. The condition comprises cancer associated with the liver, anus, pancreas, gall bladder, and bowel.

MARKET DYNAMICS

The gastrointestinal cancer devices market is expected to witness considerable growth due to growing prevalence of gastrointestinal cancer. In addition, emphasis on preventive care is also projected to offer lucrative opportunity for the market growth. However, poor infrastructure in emerging countries and stringent government regulations are expected to hamper the growth of the global gastrointestinal cancer devices market.

MARKET SCOPE

The "Gastrointestinal Cancer Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gastrointestinal Cancer Devices Market with detailed market segmentation by treatment type and end user. The Gastrointestinal Cancer Devices Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Gastrointestinal Cancer Devices Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The gastrointestinal cancer devices market is segmented on the basis of treatment type and end user. Based on treatment type, the market segmented as surgery, targeted drugs therapy, chemo therapy, and radiation therapy. Based on end user, the market is segmented as hospitals, ambulatory surgery centers, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Gastrointestinal Cancer Devices Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gastrointestinal Cancer Devices Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Gastrointestinal Cancer Devices Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Gastrointestinal Cancer Devices Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Gastrointestinal Cancer Devices Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Gastrointestinal Cancer Devices Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Gastrointestinal Cancer Devices Market.

The report also includes the profiles of key players in Gastrointestinal Cancer Devices Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Eli Lilly and company
  •  F. Hoffmann-La Roche Ltd.
  •  GlaxoSmithKline plc
  •  Merck & Co., Inc.
  •  Novartis AG
  •  Otsuka Holdings Co., Ltd.
  •  Stryker Corporation
  •  Boston Scientific Corporation
  •  Johnson & Johnson
  •  CONMED Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gastrointestinal Cancer Devices Market - By Treatment Type
1.3.2 Gastrointestinal Cancer Devices Market - By End User
1.3.3 Gastrointestinal Cancer Devices Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GASTROINTESTINAL CANCER DEVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GASTROINTESTINAL CANCER DEVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GASTROINTESTINAL CANCER DEVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. GASTROINTESTINAL CANCER DEVICES - GLOBAL MARKET OVERVIEW
6.2. GASTROINTESTINAL CANCER DEVICES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GASTROINTESTINAL CANCER DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. SURGERY
7.3.1. Overview
7.3.2. Surgery Market Forecast and Analysis
7.4. TARGETED DRUGS THERAPY
7.4.1. Overview
7.4.2. Targeted Drugs Therapy Market Forecast and Analysis
7.5. CHEMO THERAPY
7.5.1. Overview
7.5.2. Chemo Therapy Market Forecast and Analysis
7.6. RADIATION THERAPY
7.6.1. Overview
7.6.2. Radiation Therapy Market Forecast and Analysis
8. GASTROINTESTINAL CANCER DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. AMBULATORY SURGERY CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgery Centers Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. GASTROINTESTINAL CANCER DEVICES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Gastrointestinal Cancer Devices Market Overview
9.1.2 North America Gastrointestinal Cancer Devices Market Forecasts and Analysis
9.1.3 North America Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Gastrointestinal Cancer Devices Market Forecasts and Analysis - By End User
9.1.5 North America Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Countries
9.1.5.1 United States Gastrointestinal Cancer Devices Market
9.1.5.1.1 United States Gastrointestinal Cancer Devices Market by Treatment Type
9.1.5.1.2 United States Gastrointestinal Cancer Devices Market by End User
9.1.5.2 Canada Gastrointestinal Cancer Devices Market
9.1.5.2.1 Canada Gastrointestinal Cancer Devices Market by Treatment Type
9.1.5.2.2 Canada Gastrointestinal Cancer Devices Market by End User
9.1.5.3 Mexico Gastrointestinal Cancer Devices Market
9.1.5.3.1 Mexico Gastrointestinal Cancer Devices Market by Treatment Type
9.1.5.3.2 Mexico Gastrointestinal Cancer Devices Market by End User
9.2. EUROPE
9.2.1 Europe Gastrointestinal Cancer Devices Market Overview
9.2.2 Europe Gastrointestinal Cancer Devices Market Forecasts and Analysis
9.2.3 Europe Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Gastrointestinal Cancer Devices Market Forecasts and Analysis - By End User
9.2.5 Europe Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Gastrointestinal Cancer Devices Market
9.2.5.1.1 Germany Gastrointestinal Cancer Devices Market by Treatment Type
9.2.5.1.2 Germany Gastrointestinal Cancer Devices Market by End User
9.2.5.2 France Gastrointestinal Cancer Devices Market
9.2.5.2.1 France Gastrointestinal Cancer Devices Market by Treatment Type
9.2.5.2.2 France Gastrointestinal Cancer Devices Market by End User
9.2.5.3 Italy Gastrointestinal Cancer Devices Market
9.2.5.3.1 Italy Gastrointestinal Cancer Devices Market by Treatment Type
9.2.5.3.2 Italy Gastrointestinal Cancer Devices Market by End User
9.2.5.4 Spain Gastrointestinal Cancer Devices Market
9.2.5.4.1 Spain Gastrointestinal Cancer Devices Market by Treatment Type
9.2.5.4.2 Spain Gastrointestinal Cancer Devices Market by End User
9.2.5.5 United Kingdom Gastrointestinal Cancer Devices Market
9.2.5.5.1 United Kingdom Gastrointestinal Cancer Devices Market by Treatment Type
9.2.5.5.2 United Kingdom Gastrointestinal Cancer Devices Market by End User
9.2.5.6 Rest of Europe Gastrointestinal Cancer Devices Market
9.2.5.6.1 Rest of Europe Gastrointestinal Cancer Devices Market by Treatment Type
9.2.5.6.2 Rest of Europe Gastrointestinal Cancer Devices Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Gastrointestinal Cancer Devices Market Overview
9.3.2 Asia-Pacific Gastrointestinal Cancer Devices Market Forecasts and Analysis
9.3.3 Asia-Pacific Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Gastrointestinal Cancer Devices Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Gastrointestinal Cancer Devices Market
9.3.5.1.1 Australia Gastrointestinal Cancer Devices Market by Treatment Type
9.3.5.1.2 Australia Gastrointestinal Cancer Devices Market by End User
9.3.5.2 China Gastrointestinal Cancer Devices Market
9.3.5.2.1 China Gastrointestinal Cancer Devices Market by Treatment Type
9.3.5.2.2 China Gastrointestinal Cancer Devices Market by End User
9.3.5.3 India Gastrointestinal Cancer Devices Market
9.3.5.3.1 India Gastrointestinal Cancer Devices Market by Treatment Type
9.3.5.3.2 India Gastrointestinal Cancer Devices Market by End User
9.3.5.4 Japan Gastrointestinal Cancer Devices Market
9.3.5.4.1 Japan Gastrointestinal Cancer Devices Market by Treatment Type
9.3.5.4.2 Japan Gastrointestinal Cancer Devices Market by End User
9.3.5.5 South Korea Gastrointestinal Cancer Devices Market
9.3.5.5.1 South Korea Gastrointestinal Cancer Devices Market by Treatment Type
9.3.5.5.2 South Korea Gastrointestinal Cancer Devices Market by End User
9.3.5.6 Rest of Asia-Pacific Gastrointestinal Cancer Devices Market
9.3.5.6.1 Rest of Asia-Pacific Gastrointestinal Cancer Devices Market by Treatment Type
9.3.5.6.2 Rest of Asia-Pacific Gastrointestinal Cancer Devices Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Gastrointestinal Cancer Devices Market Overview
9.4.2 Middle East and Africa Gastrointestinal Cancer Devices Market Forecasts and Analysis
9.4.3 Middle East and Africa Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Gastrointestinal Cancer Devices Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Gastrointestinal Cancer Devices Market
9.4.5.1.1 South Africa Gastrointestinal Cancer Devices Market by Treatment Type
9.4.5.1.2 South Africa Gastrointestinal Cancer Devices Market by End User
9.4.5.2 Saudi Arabia Gastrointestinal Cancer Devices Market
9.4.5.2.1 Saudi Arabia Gastrointestinal Cancer Devices Market by Treatment Type
9.4.5.2.2 Saudi Arabia Gastrointestinal Cancer Devices Market by End User
9.4.5.3 U.A.E Gastrointestinal Cancer Devices Market
9.4.5.3.1 U.A.E Gastrointestinal Cancer Devices Market by Treatment Type
9.4.5.3.2 U.A.E Gastrointestinal Cancer Devices Market by End User
9.4.5.4 Rest of Middle East and Africa Gastrointestinal Cancer Devices Market
9.4.5.4.1 Rest of Middle East and Africa Gastrointestinal Cancer Devices Market by Treatment Type
9.4.5.4.2 Rest of Middle East and Africa Gastrointestinal Cancer Devices Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Gastrointestinal Cancer Devices Market Overview
9.5.2 South and Central America Gastrointestinal Cancer Devices Market Forecasts and Analysis
9.5.3 South and Central America Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Gastrointestinal Cancer Devices Market Forecasts and Analysis - By End User
9.5.5 South and Central America Gastrointestinal Cancer Devices Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Gastrointestinal Cancer Devices Market
9.5.5.1.1 Brazil Gastrointestinal Cancer Devices Market by Treatment Type
9.5.5.1.2 Brazil Gastrointestinal Cancer Devices Market by End User
9.5.5.2 Argentina Gastrointestinal Cancer Devices Market
9.5.5.2.1 Argentina Gastrointestinal Cancer Devices Market by Treatment Type
9.5.5.2.2 Argentina Gastrointestinal Cancer Devices Market by End User
9.5.5.3 Rest of South and Central America Gastrointestinal Cancer Devices Market
9.5.5.3.1 Rest of South and Central America Gastrointestinal Cancer Devices Market by Treatment Type
9.5.5.3.2 Rest of South and Central America Gastrointestinal Cancer Devices Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GASTROINTESTINAL CANCER DEVICES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GASTROINTESTINAL CANCER DEVICES MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK AND CO., INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVARTIS AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. OTSUKA HOLDINGS CO., LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. STRYKER CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BOSTON SCIENTIFIC CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. JOHNSON AND JOHNSON SERVICES INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CONMED CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Eli Lilly and company
2. F. Hoffmann-La Roche Ltd.
3. GlaxoSmithKline plc
4. Merck & Co., Inc.
5. Novartis AG
6. Otsuka Holdings Co., Ltd.
7. Stryker Corporation
8. Boston Scientific Corporation
9. Johnson & Johnson
10. CONMED Corporation
TIPRE00018054
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.